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Background: During October 2010, Egypt reported an outbreak of acute hemorrhagic conjunctivitis (AHC). A total
of 1831 cases were reported from three governorates; 1703 cases in El Daqahliya, 92 cases in Port Said, and 36 in
Damietta. The purpose of this study was to identify and characterize the causative agent associated with this
outbreak.
Methods: The U.S. Naval Medical Research Unit No.3 (NAMRU-3) was contacted by the Egyptian Ministry of Health
and Population to perform diagnostic laboratory testing on eighteen conjunctival swabs from patients with
conjunctivitis from El Daqahliya Governorate. Conjunctival swabs were tested by molecular methods for human
adenovirus (HAdV) and enteroviruses (EV). Virus isolation was performed; the isolated virus was further characterized
by molecular typing and phylogenetic analysis.
Results: The majority of the samples (17/18) were positive for enterovirus and all were negative for HAdV.
Molecular typing and sequencing of the isolated virus revealed the presence of coxsackievirus A24 variant.
Phylogenetic analysis based on the VP1 and 3C regions demonstrated that the Egyptian viruses belonged to
Genotype IV and are closely related to coxsackievirus A24 variant, reported in a similar outbreak in China in
August 2010.
Conclusions: This study strongly suggests that coxsackievirus A24 variant was associated with the acute
hemorrhagic conjunctivitis outbreak reported in Egypt in October 2010. There is a possibility that the same strain of
CV-A24v was implicated in the AHC outbreaks in both China and Egypt in 2010.
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Acute hemorrhagic conjunctivitis (AHC) is a highly conta-
gious, epidemic, eye disease characterized by eyelid swell-
ing, tearing, and conjunctival hemorrhages. AHC is most
commonly caused by two enterovirus serotypes, human en-
terovirus 70 (EV-70) and human coxsackievirus A24 variant
(CV-A24v), and less frequently by some adenovirus se-
rotypes [1]. The two major causes of AHC mentioned
above belong to the genus Enterovirus of the family
Picornaviridae [2].* Correspondence: ehab.amir.eg@med.navy.mil
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reproduction in any medium, provided the orEnteroviruses contain a positive sense single-stranded
RNA (ssRNA) genome, 7.4 kb in length, with a 740 bp
of untranslated region (UTR) at the 5' end, the RNA is
translated into a single polyprotein that is later cleaved
into the four capsid subunits (VP1-VP4) and 2B, 2C,
3AB, and 3C viral proteins involved in RNA replication
and lastly 3D the RNA-dependent RNA polymerase [2].
EV-70 belongs to the human enterovirus species D group
(HEV-D) [3], was isolated for the first time in 1970 from
the conjunctiva of patients with AHC in West Africa and
has subsequently been detected worldwide [4]. CV-A24v is
an antigenic variant of human coxsackievirus A24 strain,
both classified as members of the human enterovirus spe-
cies C group (HEV-C) [3], CV-A24v was isolated in 1970Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in which 60,000 cases were reported from September to
October [5]. The outcome of viral infections caused by ei-
ther EV-70 or CV-A24v is indistinguishable and both are
highly contagious. Following a 24–48 hour incubation
period, symptoms begin to appear as described previously
and persist for three to seven days before resolving spon-
taneously. Although the illness is mostly nonsystemic, tran-
sient lumbar radiculomyelopathy and poliomyelitis-like
illness were reported in some cases [2].
During the period 1970–1985, Southeast Asia and India
reported a number of outbreaks caused by CV-A24v [6].
From 1987–1991 several large outbreaks were reported in
Ghana, Taiwan, and some Central American countries
[7-10]. Nearly a decade later, three major outbreaks linked
to CV-A24v were reported in South Korea (2002),
Malaysia (2003) and the French West Indies, Martinique
and Guadeloupe (2003) [11-13]. Again from 2006–2007,
CV-A24v was implicated in an outbreak of AHC in
Taiwan and Yunnan, China [14,15]. During August 2010,
a huge outbreak of AHC caused by CV-A24v was reported
in Guangdong, China [16]. Recent studies identified the
presence of four distinct genotypes of CV-A24v, desig-
nated I-IV, by phylogenetic analysis of the VP1 and 3C re-
gions of the genome [14,16].
In October 2010, an outbreak of acute hemorrhagic
conjunctivitis occurred in the Nile Delta region of Egypt,
encompassing 3 governorates with 1831 suspected cases
[17]. There is no published data to record any investiga-
tion of possible previous AHC outbreaks in Egypt. The
objective of the present study was to identify and
characterize the causative agent involved in the outbreak
of AHC in Egypt, in addition identifying the relatedness
of the suspected agent to similar etiologies causing AHC
outbreaks worldwide.
Results
Virus detection and isolation results
The eighteen conjunctival swabs were tested for human
adenovirus and enterovirus by rt-PCR. All of the eighteen
samples were negative for human adenovirus, whereas
seventeen swabs (94.4%) were positive for enterovirus
RNA by (rt-RT-PCR). The seventeen positive samples
were further characterized using a RT-PCR assay for the
VP1 region that differentiates between CV-A24v and
EV-70. All of the samples were positive for a 171 bp prod-
uct corresponding to CV-A24v, and negative for a 113 bp
product corresponding to EV-70. The swabs were also in-
oculated into cell culture to isolate the virus. MRC-5 cells
were inoculated and a cytopathic effect (CPE) was ob-
served, starting at 48 hours post infection, consisting of
cell rounding and lysis. Within 4 days post infection, half
of the samples (n = 9) had CPE consistent with a viral in-
fection, at which point the virus was harvested. Bacterialgrowth was observed in the other nine samples which were
then discarded.
Sequencing and phylogenetic analysis results
We successfully obtained sequence data for analysis from
seven isolates in the 5' UTR region (327 nt), six sequences
were completely identical and the seventh sequence Egypt/
2010914560, had 99.3% nucleotide identity to the others
with no insertions or deletions. The 5' UTR sequences from
the Egyptian CV-A24v strains were compared to other glo-
bal representative sequences from GenBank, the Egyptian
sequences had a range of 87-99% nucleotide identity
(Additional file 1) among the CV-A24v strains shown on
the 5' UTR phylogenetic tree (Figure 1). In the VP4 region
we obtained sequence data from eight of the Egyptian iso-
lates (207 nt); seven of the eight sequences had 100% nu-
cleotide identity, the eighth sequence, Egypt/2010914555,
contained a single silent mutation at nucleotide number
882 with no insertions or deletions when compared to the
other identical sequences. The VP4 sequences from the
Egyptian isolates shared a range of 79-99% nucleotide iden-
tity and a range of 94-100% amino acid identity (Additional
files 2 and 3) among other strains shown on the VP4 phylo-
genetic tree (Figure 2). In the VP1 region we were able to
sequence six isolates (792 nt), five of the six sequences had
100% nucleotide identity, the sixth sequence, Egypt/
2010914555, exhibited a single silent mutation at nucleotide
number 2586 with no insertions or deletions when com-
pared to the other identical sequences. The Egyptian VP1
sequences shared a range of 85-98% nucleotide identity and
a range of 95-100% amino acid identity (Additional files 4
and 5) among other strains shown on the VP1 phylogenetic
tree (Figure 3). Analysis of the six sequences obtained from
the 3C region revealed a similar outcome as discovered in
the VP4 and VP1 regions with five of the sequences being
100% identical to one another, with the sixth sequence, also
Egypt/2010914555, containing a single silent mutation at
nucleotide number 5511 with no insertions or deletions
when compared to the other identical sequences. The 3C
sequences from the Egyptian isolates (549 nt) demonstrated
a range of 85-98% nucleotide identity, and a range of 88.5-
100% amino acid identity (Additional files 6 and 7) among
other strains shown on the 3C phylogenetic tree (Figure 4).
All of the nucleotide sequences from the four genomic re-
gions shared a common ancestor, the CV-A24v strain
China/GD46/10 [JF742576], an isolate from a 2010 out-
break of AHC, with 98-99% similarity based on results from
BLASTn. All the VP4, VP1 and 3C sequences obtained
from the Egyptian isolates had 100% amino acid identity to
the China/GD46/10 strain.
In examining the VP4 region, 34 to 35 nucleotide dif-
ferences were identified between the sequence of the
Egyptian isolates and the prototype strain EH24/70, with
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Figure 1 Phylogenetic tree based on a partial sequence of the 5´UTR region (327 nt). The tree was created with MEGA4 using the
neighbor joining method and genetic distances were estimated using the maximum composite likelihood evolutionary model. The tree was
rooted to the prototype strain of human coxsackievirus A24 variant, EH24/70 isolated from Singapore in 1970 [D90457]. Bootstrap values less than
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Figure 2 Phylogenetic tree of the VP4 region (207 nt). The tree was created with MEGA4 using the neighbor joining method and genetic
distances were estimated using the maximum composite likelihood evolutionary model. The tree was rooted to the prototype strain of human
coxsackievirus A24 variant, EH24/70 isolated from Singapore in 1970 [D90457]. Bootstrap values less than 70% were omitted. GenBank accession
numbers are shown between brackets to the right of the strain name.
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Figure 3 Phylogenetic tree of the VP1 region (792 nt). The tree was created with MEGA4 using the neighbor joining method and genetic
distances were estimated using the maximum composite likelihood evolutionary model. The tree was rooted to the prototype strain of human
coxsackievirus A24 variant, EH24/70 isolated from Singapore in 1970 [D90457]. Bootstrap values less than 70% were omitted. GenBank accession
numbers are shown between brackets to the right of the strain name. Four Genotypes are shown on the tree.
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amino acid change in all of the eight VP4 sequences from
Egypt, while the remainders were synonymous (Figure 5).
We also identified, 113–114 nucleotide differences between
the Egyptian VP1 sequences and the prototype strain, with
no insertions or deletions, these differences resulted in 13
nonsynonymous substitutions; S11T, L25H, S32L, V51A,
I56V, M89I, E100D, K103R, T146A, Y151H, I196M, F250Y
and I256T in all of the six VP1 sequences obtained
(Figure 6). The 3C region of the Egyptian isolates contained
79 nucleotide differences as compared with the prototype
strain, again with no insertions or deletions, the 79 nucleo-
tide differences resulted in six nonsynonymous substitu-
tions; I15V, V54I, V114I, N139H, I151V and M160I in all
six 3C sequences obtained (Figure 7).
Analysis of the 5' UTR and VP4 phylogenetic trees re-
vealed that the Egyptian sequences are clustered into a
single monophyletic group with the most closely related
sequence the China/GD46/10 which was also the common
ancestor based on BLASTn analysis. EH24/70 is genetically
distant from all of the other isolates including the Egyptian
isolates; the VP4 tree was more comprehensive than the
5’UTR tree due to the larger availability of sequences in this
region from past outbreaks. The phylogenetic trees based
on the VP1 and 3C regions were quite similar, the Egyptianisolates forming a single cluster with the most closely re-
lated sequence the China/GD46/10 again in agreement
with the BLASTn results and the previous analysis. In these
trees, the EH24/70 remained the most distantly related but
the VP1 and 3C trees were more comprehensive and in-
formative than the 5’UTR and VP4 trees, with four distinct
genotypes arranged chronologically. The VP1 phylogenetic
tree represented a more clearly chronological evolution of
the CV-A24v than the 3C tree.
Discussion
This study identified a viral agent associated with a small
number of cases of AHC during an outbreak in Egypt.
We ruled out the presence of human adenovirus and deter-
mined that a human enterovirus was present by rt-RT-PCR.
We used specific primer pairs in the VP1 region of the
enterovirus genome to distinguish between CV-A24v and
EV-70. The amplification product consistent with CV-A24v
indicated its implication in this outbreak. We further con-
firmed the presence of CV-A24v by sequencing four gen-
omic regions, including the VP4, which has been cited as a
suitable method for molecular serotyping in lieu of the clas-
sic homo-typic seroneutralisation assays [18], as well as the
VP1 region which is considered to be the best region for
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Figure 4 Phylogenetic tree of the 3C region (549 nt). The tree was created with MEGA4 using the neighbor joining method and genetic
distances were estimated using the maximum composite likelihood evolutionary model. The tree was rooted to the prototype strain of human
coxsackievirus A24 variant, EH24/70 isolated from Singapore in 1970 [D90457]. Bootstrap values less than 70% were omitted. GenBank accession
numbers are shown between brackets to the right of the strain name. Four Genotypes are shown on the tree.
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sequence was found to match with classical serotypes
[19,20]. The taxonomy report obtained upon Blasting the
VP4 and VP1 sequences from Egypt strongly suggested the
presence of CV-A24v.
The source of introduction of this virus to Egypt is un-










Figure 5 Amino acid alignment of the VP4 region of the Egyptian CV
between strains are shown as dots.from a city in El Daqahliya had made frequent trips to sev-
eral African countries and could have imported the virus.
Additionally, other media reports indicated that there was
significant air pollution due to burning rice straw during
the time of the outbreak which could have led to a non-
infectious conjunctivitis. However, without an epidemio-



































Figure 6 Amino acid alignment of the VP1 region of the Egyptian CV-A24v with the prototype strain EH24/70. Identical amino acids
between strains are shown as dots.
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parts of the world in 2010. Uganda and Southern Sudan
reported AHC outbreaks caused by CV-A24v during June
and July respectively [21]. Pakistan and Mexico reported
conjunctivitis outbreaks [22,23] during September and al-
though no etiology was demonstrated, local authorities pre-
sumed that the outbreak was of viral origin. Lastly, there
was also a severe outbreak of AHC reported in Guangdong,
China during the period August-October and was attrib-
uted to CV-A24v [16]. Although there is no data to indicate
how the virus was introduced to Egypt, the rapid dissemin-
ation among school students (59.7% of cases were students)
indicates that it probably did spread within schools once
introduced.
In order to understand the relatedness of the Egyptian
virus isolates, we sequenced four different genomic re-
gions. The high degree of similarity (>99%) among the
strains in each of these regions indicates that there was
likely a single source or introduction that caused this
outbreak. Moreover, the very high nucleotide identity
















Figure 7 Amino acid alignment of the 3C region of the Egyptian CV-A
between strains are shown as dots.reported in Guangdong, China in 2010, suggests that the
same virus might be implicated in both outbreaks. It is
known that CV-A24v is highly contagious in a world
with an incredibly mobile population.
Most studies of AHC outbreaks caused by CV-A24v
used the VP1 and 3C regions as tool for molecular epi-
demiological analysis and four distinct genotypes of a
CV-A24v strains were identified [14,16]. However, the
VP1 region is more informative than the 3C region to
describe the molecular epidemiology of enteroviruses, by
virtue of the high recombination rates among enterovi-
ruses and the liability of the VP1 region to mutate fre-
quently to evade the immune response, which makes the
VP1 region evolve at a faster rate when compared to the
3C region [24].
The strains shown on the VP1 phylogenetic tree
(Figure 3) were grouped into four genotypes. Genotype I
(G I) consisted of the prototype strain EH24/70, Geno-
type II (G II) consisted of strains from 1987, Genotype
III (G III) contained strains from the 1990s, and Genotype
















24v with the prototype strain EH24/70. Identical amino acids
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were among Genotype IV with other strains from China,
India, Singapore and Spain. The 3C phylogenetic tree also
demonstrated four distinct genotypes. Genotype I (G I)
consisted of the prototype strain EH24/70 and other
strains isolated from Singapore in 1970, Genotype II (G II)
consisted of strains from 1975, Genotype III (G III)
contained strains from the 1980s, and Genotype IV (G IV)
is composed of a more diverse group of strains isolated
from 2002–2010. The CV-A24v strains isolated from
Egypt during 2010 were included in Genotype IV with
other strains from China, Cuba, India, Taiwan, South Korea
and French Guiana (Figure 4). The phylogenetic trees based
on the VP1 and 3C regions echo the fact that four distinct
genotypes of CV-A24v were previously identified [14,16].
Some sites in the affected areas are located on the
Mediterranean Sea with active ports and extensive trading
activity with other foreign countries, especially China; so
this may be considered as a means for the introduction of
this virus in Egypt. High population density and poor sani-
tation in some of these areas may be factors that contribute
to the rapid dissemination of the virus, especially in rural
locations where people may share towels and other per-
sonal belongings.
Conclusions
This investigation strongly implicates CV-A24v strain as
being associated with the conjunctivitis cases reported
from Egypt in October 2010. Further characterization of
CV-A24v by sequencing revealed that it belonged to
Genotype IV. There is a possibility that the same strain of
CV-A24v was the causative agent in the AHC outbreaks
in China and Egypt in 2010. We strongly recommend in-
creasing awareness of symptoms, treatment and preven-
tion of AHC, as well as the implementation of control




The outbreak of AHC investigated in this study occurred
in late October, and affected three adjacent coastal gov-
ernorates in the Nile Delta region of Egypt. A total of
1831 conjunctivitis cases were reported by local ophthal-
mologists in the region, 59.7% of the cases were stu-
dents. El Daqahliya Governorate, the largest of the three
governorates, had the largest number of cases at 1703,
of which 1042 were students. Port Said Governorate and
Damietta Governorate had considerably fewer cases at
92 and 36 respectively. A viral etiology was suspected by
ophthalmologists, the Egyptian Central Public Health
Laboratory (CPHL) in Cairo requested the ophthalmolo-
gists to collect representative samples from symptomatic
patients reported to the hospitals to identify the etiologyof the outbreak. NAMRU-3 was contacted to assist in
the identification of the causative agent.
Clinical samples from AHC cases
Conjunctival swabs in viral transport medium (VTM)
containing 2.5% veal infusion broth, 0.5% bovine serum al-
bumin, 100 μg/ml gentamicin sulfate, 2 μg/ml fungizone
(amphoterecine B) were collected from 18 symptomatic
patients from El Daqahliya Governorate, north of Cairo.
The patients’ ages ranged from 3–68 years, 15 were males
and 3 were females. Reported symptoms included inflam-
mation of the conjunctiva, increased tearing, redness and
itching of the eyes. The swabs were transferred to the
(CPHL) in Cairo, then to NAMRU-3 for investigation.
Virus detection and isolation
RNA extraction was performed on 140 μl of sample using
the QiagenW QIAampW Viral RNA Mini Kit according to
the manufacturer’s specifications (Qiagen Inc.,Valencia,
CA). Real-Time PCR was used to detect human adeno-
virus using the protocol and primers developed by the
Centers for Disease Control and Prevention (CDC)
Atlanta, GA, USA [25]. Real-time reverse-transcription
PCR (rt-RT-PCR) was performed to detect enteroviruses
using published primers [26] targeting the highly con-
served 5' UTR. The reaction contained 8 μl RNA, 300 nM
forward primer, 900 nM reverse primer, 150 nM dual-
labeled fluorogenic probe, 0.4 mM dNTPs, 4 μl buffer
(Qiagen One-Step RT-PCR kit, Qiagen Inc., Valencia, CA)
and 0.8 μl Qiagen One-Step enzyme mix in a total reac-
tion volume of 20 μl. The cycling conditions were as fol-
lows: 50°C for 30 min, 95°C for 15 min, 40 cycles of 94°C
for 15 sec and 60°C for 1 min and performed on an
ABI7500 (Applied Biosystems, Foster City, CA). Entero-
virus positive samples were then tested for CV-A24v and
EV-70 using conventional RT-PCR reactions utilizing the
primer pairs (S-3, AS-3) and (S-4, AS-4) targeting the VP1
region of the enterovirus genome and specific to CV-A24v
and EV-70 respectively [27], the reaction contained 10 μl
RNA, 1.5 mM MgSO4, 0.2 mM dNTPs, 5 μl Buffer
(Promega Access RT-PCR kit, Madison, USA), 0.8 μM for-
ward primer, 0.8 μM reverse primer, 0.5 μl Promega RT
enzyme and 0.5 μl Promega DNA polymerase in a total re-
action volume of 25 μl. Cycling conditions were as follows:
48°C for 45 min, 94°C for 2 min, 40 cycles of 94°C for
30 sec, 60°C for 30 sec, 68°C for 1 min followed by 68°C
for 7 min. 5 μl of amplified product was visualized on a
3% agarose gel.
We also inoculated 100 μl of each of the samples onto
a MRC-5 (CCL-171 American Type Culture Collection,
Manassas, Virginia, USA) monolayer in culture tubes
after the growth media was discarded. The tubes were
incubated at 37°C in 5% CO2 for one hour and rocked
every 15 minutes. One ml of DMEM media (Dulbecco’s
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NY, USA) was added to each tube and then incubated at
37°C in 5% CO2. The cells were observed for cytopathic ef-
fect (CPE) for seven days. When CPE was observed, the
positive samples were frozen at −70°C to maintain the virus
viability for further characterization. RNA was extracted
from each of the isolates using the method described above,
and the RNA was used as a template for the sequencing
reactions.
Sequencing and phylogenetic analysis
In order to confirm that the virus isolates were CV-A24v,
further characterization and genomic analysis were
performed after sequencing portions of the genome. Four
genomic regions were sequenced: a portion of the 5'
UTR [28], the entireVP4 [18], the partial VP1 [16] and
the partial 3C [29], using conventional RT-PCR. 5 μl of
nucleic acid extracted from the virus isolates were used
for amplification in a total volume of 25 μl containing:
1.5 mM MgSO4, 0.2 mM dNTPs, 5 μl Buffer (Promega Ac-
cess RT-PCR Kit, Madison, USA), 0.8 μM forward primer,
0.8 μM reverse primer, 0.5 μl Promega RT enzyme and
0.5 μl Promega DNA polymerase. Cycling conditions were
as follows: 48°C for 45 min, 94°C for 2 min, 33 cycles of
94°C for 30 sec, 52°C for 30 sec, 68°C for 1 min, followed
by 68°C for 7 min. 5 μl of the amplified products were visu-
alized on a 2% agarose, however a 1% agarose was prepared
to visualize the VP1 region. The expected band sizes were
410 bp, 650 bp, 1032 bp and 674 bp for the 5' UTR, VP4,
VP1 and 3C respectively. Amplified products of the appro-
priate size were purified using ExoSAP-IT (USB, Cleveland,
OH) and bi-directionally sequenced using the same primers
used for amplification of the four regions cited above
[16,18,28,29]. Each sequencing reaction was done using
4 μl of the BigDye Terminator v3.1 cycle sequencing kit
(Applied Biosystems, Foster City, CA, USA), 4 μl of the
BigDye Terminator v3.1 sequencing buffer, 2 μl of the puri-
fied amplified product, 1 μl of 3.2 μM primer in a total vol-
ume of 21 μl. Cycling conditions were as follows: 26 cycles
of 96°C for 10 sec, 50°C for 5 sec and 60°C for 4 min. The
cycle sequencing products were purified using the BigDye
XTerminator purification kit (Applied Biosystems, Foster
City, CA, USA) according to the kit instructions and then
analyzed on ABI3130xl genetic analyzer. Sequences were
edited using the Sequencher software V4.10.1 (Gene Codes,
Ann Arbor, MI, USA). All obtained sequences were used
for a database search, performed using BLASTn (National
Center for Biotechnology Information, Bethesda, MD,
USA) to determine which viral sequence these samples
were most closely related to. Multiple sequence alignments
were generated using the BioEdit software for each of the
sequenced regions with some CV-A24v representative se-
quences from GenBank to determine the relatedness of the
Egyptian isolates involved in this outbreak to other globalCV-A24v isolates. Percentage similarity between sequences
was calculated using the sequence identity matrix, BioEdit.
The nucleotide multiple sequence alignment from each of
the regions was used as an input to create phylogenetic
trees with MEGA 4 software [30] using the neighbor-
joining method. Genetic distances were estimated using the
maximum composite likelihood evolutionary model, and
bootstrap analysis was implemented with 1000 replicates.
The generated phylogenetic trees were rooted to the proto-
type strain of human coxsackievirus A24 variant, EH24/70
isolated from Singapore in 1970 [D90457]. Bootstrap values
less than 70% were omitted. GenBank accession numbers
for the downloaded strains are shown on the trees.
The 5'UTR sequences obtained from the Egyptian
isolates were given GenBank accession numbers from
[JX826501-JX826507], the VP4 sequences from [JX826487-
JX826494], the VP1 sequences from [KC676721-KC676726]
and the 3C from [JX826495-JX826500].
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